Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transient receptor potential canonical (TRPC) channels are a subfamily of non-selective cation channels that mediate the influx of calcium and sodium ions in response to various stimuli. They are involved in diverse cellular processes including sensory perception, cardiac function, and cell migration, making them potential therapeutic targets for diseases like cardiovascular disease and cancer. Activation occurs through physical stimuli (mechanical stretch, temperature), chemical signals (pH, ROS), and G-protein-coupled receptor signaling. The channels function as tetramers, with each subunit containing six transmembrane segments. Several small molecule modulators have been identified as potential preclinical drug candidates.
Modulation of ion channel activity, influencing calcium and sodium influx, thereby altering downstream signaling pathways.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transient Receptor Potential Canonical Ion Channel (None).